Nicotinic acid mononucleotide triethylamine

• CAT Number: I041428
• Molecular Formula: C11H14NO9P.1.7C6H15N
• Molecular Weight: 506.97
• Purity: ≥95%
• IUPAC Name: N,N-diethylethanamine;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxylate
• InChI: InChI=1S/C11H14NO9P.C6H15N/c13-8-7(5-20-22(17,18)19)21-10(9(8)14)12-3-1-2-6(4-12)11(15)16;1-4-7(5-2)6-3/h1-4,7-10,13-14H,5H2,(H2-,15,16,17,18,19);4-6H2,1-3H3/t7-,8-,9-,10-;/m1./s1
• InChIKey: GPZFNHRXVDUKEM-WFFMJNDQSA-N
• SMILES: CCN(CC)CC.C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)C(=O)[O-]

Nicotinic acid mononucleotide triethylamine (Cat No.:I041428) is a derivative of nicotinic acid mononucleotide (NAMN), a precursor in the synthesis of nicotinamide adenine dinucleotide (NAD+). This compound is commonly used in biochemical research to study NAD+ metabolism and its role in cellular processes such as energy production, DNA repair, and cellular stress response. NAMN-TEA provides a more stable form of NAMN for experimental use. Its potential therapeutic applications include aging, neurodegenerative diseases, and metabolic disorders, as NAD+ is crucial for maintaining cellular function and homeostasis. Ongoing research explores its broader clinical uses.